Back to 
UBS Group AGTMTMED
UBS Group AGTMTMED2 quarters
Position history for UBS Group AG's holdings in T ROWE PRICE EXCHANGE-TRADED
UBS Group AG previously held 0 shares of TMED (T ROWE PRICE EXCHANGE-TRADED), worth $0 as of 2026-Q1.
Final Value
$0
Final Shares
0
Total Value Change
-$1,546
Total Shares Change
-52
Quarter-by-Quarter History
Other major holders of TMED: CITADEL ADVISORS LLC, COMMONWEALTH EQUITY SERVICES, LLC